Experimental treatment aims to free hepatitis b patients from daily pills
NCT ID NCT07069569
Summary
This study is testing whether a new injection called AHB-137, when given alongside other hepatitis B treatments, can help patients with a certain type of chronic hepatitis B safely stop their long-term antiviral pills. Researchers will enroll 127 adults who are already taking antiviral medication to see if the combination treatment can keep the virus undetectable after stopping the pills. The main goal is to see if patients can maintain low virus levels 24 weeks after ending all treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.